Cat. No. | Product name | CAS No. |
DCC1720 |
Ddr-trk-1n
Negative control for DDR-TRK-1 |
|
DCC1721 |
Dea Nonoate Sodium Salt
NO donor, generating a controlled release of nitric oxide in solution. |
138475-09-9 |
DCC1722 |
Deacm-caged D-luciferin
Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm |
|
DCC1723 |
Deac-pda-atp
Fluorophore to myosin or actomyosin |
807621-54-1 |
DCC1724 |
Debio-1452-nh3
Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli |
|
DCC1725 |
Deferasirox Ferrate(iii) Tripotassium Complex
Deferasirox iron complex |
554445-58-8 |
DCC1726 |
Deferoxamine Hydrochloride
Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile |
1950-39-6 |
DCC1727 |
Degrader Bt1
Novel selective degrader of BCR-ABL over c-ABL in leukemia cancer cells |
|
DCC1728 |
Dehydrorabelomycin
Natural polyketide matabolite |
30954-70-2 |
DCC1729 |
Delcasertib
Novel selective δ-protein kinase C inhibitor |
949100-39-4 |
DCC1730 |
Delta-tocopherol
Vitamin E variant, inhibiting prostate adenocarcinoma, lung tumorigenesis, promoting thermogenic gene expression via PGC-1α upregulation, preventing methylglyoxal-induced apoptosis by reducing ROS generation and inhibiting apoptotic signaling cascades |
119-13-1 |
DCC1731 |
Demethoxyviridin
Potent inhibitor of PI3 kinases |
56660-21-0 |
DCC1732 |
Denagliptin Tosylate
Selective DPP-IV Inhibitor |
811432-66-3 |
DCC1733 |
Denaverine Hydrochloride
Antispasmodic agent, improving the elasticity of the soft birth canal and regulating labor contractions |
3321-06-0 |
DCC1734 |
Denosomin
Novel anti-Alzheimer's disease agent, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin |
|
DCC1735 |
Denv2-in-1
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described |
|
DCC1736 |
Denv2-in-2
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described |
|
DCC1737 |
Denv2-in-3
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described |
|
DCC1738 |
Deox B 7,4
Novel reversible microtubule inhibitor, increasing lysosomal V-ATPase activity and lysosome acidity |
674786-37-9 |
DCC1739 |
Deoxy-dalsir
Novel selective and sensitive near-infrared fluorescent probe for visualization of endogenous nitric oxide in living cells and animals |
|
DCC1740 |
Deoxynybomycin
Selective anti-tumor agent, inducing apoptosis and inhibiting topoisomerase I |
27259-98-9 |
DCC1741 |
Depmpo
Most efficient spin trap for the in vitro and in vivo detection of O-, N-, S- and C-centered free radicals |
157230-67-6 |